Stay updated on MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial page.

Latest updates to the MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial page
- Check7 days agoChange DetectedScreenshots indicate only minor UI/layout changes with no observable modifications to core study content (inclusion criteria, locations, enrollment, or outcome measures). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check14 days agoNo Change Detected
- Check35 days agoChange DetectedMajor update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.SummaryDifference5%

- Check42 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.1%

- Check57 days agoChange DetectedUpdated revision from v3.0.1 to v3.0.2; removed the Back to Top element as a minor UI change.SummaryDifference0.3%

- Check64 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.3%

- Check71 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as new content related to various proteins and immunological components. Notably, the revision number has been updated to v3.0.0, indicating a major change.SummaryDifference4%

Stay in the know with updates to MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MIW815 +/- Ipilimumab in Solid Tumors Clinical Trial page.